Market Cap

Kuros Biosciences AG Market Capitalization:

CHF163.1 Million

CHF as of Jan. 1, 2024

US$193.7 Million

business Kuros Biosciences AG Company Profile

Kuros Biosciences AG Main Stock Listing

SIX: KURN

Market Capitalization History of Kuros Biosciences AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Kuros Biosciences AG market cap

Date Market Cap YoY Change
Jan. 1, 2024 CHF163.1 M 178.90%
Jan. 1, 2023 CHF58.5 M -24.88%
Jan. 1, 2022 CHF77.8 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Kuros Biosciences AG Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

Kuros Biosciences AG has the following listings and related stock indices.


Stock: SIX: KURN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.